Media Thread, page-11636

The FDA has certainly stepped up their focus on CAR T cell products and Gene Therapy .... Azer-cel's value as an allogeneic CAR T product could increase as time goes by, especially with the black box warning requirements I have read for current providers


GLTAH


Guidance Alert: #FDA has published final guidance on considerations for the development of CAR T cell products. Join #CBEROTP's webinar on Thursday, March 7 to hear experts share takeaways from this guidance. Registrants can submit questions in advance. https://bit.ly/3UhX04M







Guidance Alert: FDA published a final guidance on human #GeneTherapy products incorporating human genome editing. Join #CBEROTP for a webinar on Feb. 29 to hear from #FDA experts on key takeaways from this guidance. Register & submit questions here. https://bit.ly/3HARmTI